The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels

Malignant and non-malignant serosal fluids were found to be associated with high serum levels of CA-125, suggesting that the presence of fluid in the serosal cavities may stimulate its release. In this study, we investigated the relationship between serum CA-125 levels and peritoneal irritation during continuous ambulatory peritoneal dialysis (CAPD). We performed a clinical study in 24 stable patients (15 amenstrual females and 9 males), aged 46 +/- 14 years on CAPD. The control group consisted of 32 healthy volunteers (20 females, 12 males) aged 44 +/- 12 years. CA-125 levels were determined prior to the CAPD dwell (without dialysate in abdomen) and during the CAPD dwell (dialysate in abdomen 4 hours after). As a result, serum CA-125 levels were found to be 14.86 +/- 5.98 U/ml and 15.23 +/- 6.05 U/ml respectively, whereas it was 8.32 +/- 5.54 U/ml in the control group. Serum CA-125 levels were found to be significantly elevated in CAPD patients when compared with healthy volunteers. However, serum CA-125 levels detected prior to and after CAPD did not differ between the groups. Interestingly, all of the patients in our study group were detected to have normal serum CA-125 levels (< 35 U/ml). We concluded that CAPD-induced abdominal artificial ascites did not affect serum levels of CA-125. Moreover, short and non-inflammatory mechanical pressures in the CAPD procedure do not have any effect on serum CA-125 levels.

Continuous ambulatory peritoneal dialysis; CA-125

[1] Jacobs I., Bast R.C.: "The CA-125 tumor-associated antigen: A review of the literature". Hum. Reprod., 1989, 4, 1.

[2] Bischof P.: "What do we know about the origin of CA-125?". Eur. J. Obstet. Gynecol. Reprod. Biol., 1993, 49 (112), 93.

[3] Zeimet A.G., Offner F. A., Muller-Holzner E., Widschwendter M., Abendstein B., Fuith L. C.: "Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125". Tumour Biol., 1998, 19, 275.

[4] Zeimet A.G., Marth C., Offner F. A., Obrist P., Uhl-Steidl M., Feichtinger H. et al.: "Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125". Gynecol. Oncol., 1996, 62, 384.

[5] Sevinc A., Btiytikberber S., Sari R., Turk H. M., Ates M.: "Elevated serum CA-125 levels in patients with nephrotic syndromeinduced ascites". Anticancer Res., 2000, 20, 1201.

[6] Sevinc A., Btiytikberber S., Sari R., Kiroglu Y., Turk H. M., Ates M.: "Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardia! fluids". Gynecol. Oncol., 2000, 77 (2), 254.

[7] Sevinc A., Btiytikberber S., Sari R.: "Elevated serum CA-125 levels: Hepatitis or Ascites?". GynecoL Oncol., 2000, 76 (1), 141.

[8] Sari R., Btiytikberber S., Sevinc A., Ates M., Balat 0., Hascalik S., Turk M.: "The effects of abdominal and bimanual pelvic examination and transvaginal ultrasonography on serum CA-125 levels". Clin. Exp. Obst. & Gyn., 2000, 27, 69.

[9] Sari R., Camci C., Sevinc A., Demirbilek 0., Ertas E., Biiyiikberber S.: "The effect of abdominal surgery on serum CA-125 levels". Clin. Exp. Obst. & Gyn., 2000, 27, 244.

[10] Bastani B., Chu N.: "Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: The effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation". Am. J. Nephrol., 1995, 15, 468.

[11] Kawabe T., Ishii M., Sugimoto M., Tagawa H.: "Low serum CA125 concentration in chronic renal failure treated with continuous ambulatory peritoneal dialysis". Clin. Chim. Acta, 1987, 168 (1), 113.

[12] Passadakis P., Panagoutsos S., Thodis E., Tsivara I., Sopassi P., Kartali S., Vargemezis V.: "Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients". Adv. Perit. Dial., 1999,15, 40.

[13] Lai K. N., Lai K. B., Szeto C. C., Ho K. K., Poon P., Lam C. W., Leung J. C.: "Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters". Am. J. Kidney Dis., 1997, 9 (5), 699.

[14] Ho-dac-Pannekeet M. M., Hiralall J. K., Struijk D. G., Krediet R. T.: "Longitudinal follow-up of CA-125 in peritoneal effluent". Kidney Int., 1997, 51 (3), 888.

[15] Pannekeet M. M., Koomen G. C., Struijk D. G., Krediet R. T.: "Dialysate CA-125 in stable CAPD patients: no relation with transport parameters". Clin. Nephrol., 1995, 44 (4), 248.

[16] Koomen G. C., Betjes M. G., Zemel D., Krediet R. T., Hoek F. J.: "Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis". Perit. Dial. Int., 1994, 14 (2), 132.